Christopher Colyn Petter

Mr. Christopher Colyn Petter

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2026 in Micromachines
Verified
Journal Article
Open access
PDF file
BJBum-Joon Jung
Bum-Joon Jung
NTNan Tian
Nan Tian
CPChristopher Colyn Petter
Christopher Colyn Petter
SMSai Rama Krishna Meka
Sai Rama Krishna Meka
MLMichael Justin Liptay
Michael Justin Liptay
JZJian Zhou
Jian Zhou
Microfluidic cell lysis is a critical front-end step in modern bioanalysis, determining how effectively intracellular nucleic acids, proteins, metabolites, and organelles can be released, preserved, and analyzed. This review discusses how microfluidic platforms are reshaping cell lysis by enabling precise control over sample volume, reaction time, transport, mechanical forces, electrical fields, heat transfer, and spatial compartmentalization. Rather than treating lysis as an isolated disruption process, this review examines it as an integrated engineering problem that must be matched to the target cell type, analyte class, and downstream analytical workflow. It first introduces the importance of lysis in bioanalytics and the advantages of microscale systems over conventional bench-scale methods. It then discusses the major design principles that govern on-chip lysis, including reagent delivery, physical force generation, selective membrane disruption, single-cell compartmentalization, and compatibility with amplification, spectroscopy, mass spectrometry, and sequencing. Subsequent sections compare how different microfluidic architectures support bulk processing, selective lysis, single-cell analysis, subcellular fractionation, and sample-to-answer diagnostics. Emphasis is placed on the trade-offs among lysis efficiency, analyte integrity, throughput, device complexity, reagent compatibility, and clinical or field deployability. The review also highlights emerging trends in hybrid lysis platforms, automated workflows, intelligent droplet manipulation, spatially resolved omics, and low-cost diagnostic systems. Finally, it identifies persistent bottlenecks, including debris-induced clogging, limited throughput for rare-cell samples, fabrication cost, and inconsistent benchmarking across studies. Overall, this review provides a framework for understanding and selecting microfluidic lysis strategies according to analytical purpose rather than technique alone.